Indications
Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.
Composition
- Active substance
- follitropin delta
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Rekovelle
- Active substance
- follitropin delta
- ATC code
- G03GA10
- Therapeutic area
- Anovulation
- Marketing authorisation holder
- Ferring Pharmaceuticals A/S
- Status
- Authorised